Mariner, LLC Exelixis, Inc. Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Mariner, LLC holds 18,018 shares of EXEL stock, worth $649,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,018

Previous 18,931 4.82%

Holding current value

$649,909

Previous $425,000 9.88%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$21.96 - $27.6 $20,049 - $25,198	-913 Reduced 4.82%	18,018 $467,000
Q2 2024 Aug 13, 2024	BUY	$20.34 - $23.73 $5,390 - $6,288	265 Added 1.42%	18,931 $425,000
Q1 2024 May 15, 2024	BUY	$20.17 - $23.93 $36,164 - $42,906	1,793 Added 10.63%	18,666 $442,000
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $59,290 - $74,320	-3,080 Reduced 15.44%	16,873 $404,000
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $40,231 - $48,049	2,113 Added 11.84%	19,953 $435,000
Q2 2023 Aug 11, 2023	BUY	$18.17 - $20.48 $27,727 - $31,252	1,526 Added 9.35%	17,840 $340,000
Q1 2023 May 12, 2023	SELL	$16.3 - $19.41 $162,576 - $193,595	-9,974 Reduced 37.94%	16,314 $316,000
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $32,597 - $37,892	2,179 Added 9.04%	26,288 $422,000
Q3 2022 Nov 10, 2022	BUY	$15.68 - $22.27 $501 - $712	32 Added 0.13%	24,109 $378,000
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $21,643 - $28,741	-1,241 Reduced 4.9%	24,077 $501,000
Q1 2022 May 13, 2022	BUY	$17.03 - $22.67 $59,605 - $79,345	3,500 Added 16.04%	25,318 $574,000
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $22,191 - $30,653	1,401 Added 6.86%	21,818 $399,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $25,900 - $33,591	1,589 Added 8.44%	20,417 $432,000
Q2 2021 Aug 24, 2021	SELL	$17.95 - $25.56 $14,503 - $20,652	-808 Reduced 4.11%	18,828 $343,000
Q1 2021 May 07, 2021	SELL	$20.53 - $25.22 $17,204 - $21,134	-838 Reduced 4.09%	19,636 $443,000
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $110,634 - $149,196	6,016 Added 41.61%	20,474 $411,000
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $10,272 - $13,389	-497 Reduced 3.32%	14,458 $354,000
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $17,315 - $28,845	1,052 Added 7.57%	14,955 $355,000
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $30,279 - $45,649	-2,094 Reduced 13.09%	13,903 $239,000
Q4 2019 Feb 13, 2020	SELL	$15.15 - $18.89 $21,740 - $27,107	-1,435 Reduced 8.23%	15,997 $282,000
Q3 2019 Nov 13, 2019	BUY	$17.68 - $22.65 $5,038 - $6,455	285 Added 1.66%	17,432 $308,000
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $50,391 - $65,884	2,662 Added 18.38%	17,147 $366,000
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $283,906 - $358,648	14,485 New	14,485 $345,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account